The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Chylothorax
See also: Tsiouprou, I., et al., Dasatinib-induced chylothorax in a patient with chronic myeloid leukemia. Pneumon, 2018; 31: 183-186
Publications
Drug-induced chylothorax as a rare pleural complication in dasatinib therapy for chronic myeloid leukaemia.
The journal of the Royal College of Physicians of Edinburgh 2024 Mar;54;44-47 — 2024 Mar — 44-47
Dasatinib-associated chylothorax in a pediatric patient with chronic myeloid leukemia: a case report and literature review.
Translational cancer research 2023 Jan 30;12;194-200 — 2023 Jan 30 — 194-200
Dasatinib-induced chylothorax in a patient with chronic myeloid leukaemia: a case report and literature review.
Respirology case reports 2021 Jun;9;e00753 — 2021 Jun — e00753
Dasatinib-induced chylothorax: report of a case and review of the literature.
Investigational new drugs 2020 10;38;1627-1632 — 2020 10 — 1627-1632
Dasatinib-induced Chylothorax in Chronic Myelogenous Leukemia in Pediatric Patient: Report of a Case and Review of Literature.
Journal of pediatric hematology/oncology 2019 Oct 29;; — 2019 Oct 29
Dasatinib-induced chylothorax in chronic myeloid leukemia.
Proceedings (Baylor University. Medical Center) 2017 Jan;30;71-73 — 2017 Jan — 71-73
Dasatinib-induced pleural effusions: a lymphatic network disorder?
The American journal of the medical sciences 2009 Nov;338;414-7 — 2009 Nov — 414-7